ADPT vs EIX · rev $179.0M vs P/E 7.3, rev $17.60B
Adaptive Biotechnologies Corp (ADPT) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported ADPT revenue for 2024-12-31 was $179.0M. Net income was -$159.6M. Revenue was up 5.1% from 2023-12-31 to 2024-12-31. ADPT currently screens at market cap $2.69B.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
ADPT currently screens at market cap $2.69B. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the ADPT and EIX stock pages for the full models.
Not investment advice.